An Experience with Cuban Biotech's Nasalferon to Prevent SARS-COV-2 Infections in International Travelers and their Contacts.

Cañete, Roberto; León, Lizbet M; Rodríguez, Layvis

Cañete, Roberto; León, Lizbet M; Rodríguez, Layvis.

Cañete R; Medical University of Matanzas, Cuba.
León LM; Medical University of Matanzas, Cuba.
Rodríguez L; Medical University of Matanzas, Cuba.

MEDICC Rev ; 23(2): 10, 2021 04.

Article in English | MEDLINE | ID: covidwho-1224442

Subject(s)

Antiviral Agents/administration & dosage; COVID-19/prevention & control; Interferon alpha-2/administration & dosage; Travel; Virus Replication/drug effects; Administration, Intranasal; COVID-19/epidemiology; COVID-19 Testing; Cuba/epidemiology; Humans; Pandemics; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Travel / Virus Replication / Interferon alpha-2 / COVID-19 Type of study: Diagnostic study / Observational study Limits: Humans Country/Region as subject: Caribbean / Cuba Language: English Journal: MEDICC Rev Journal subject: Public Health Year: 2021 Document Type: Article Affiliation country: Mr2021.V23.N2.1

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google